Blog
Morton’s Neuroma Symptoms: How to Tell It’s Not Just Foot Pain
A burning sensation in the ball of the foot. A feeling like there’s a pebble in your shoe, even when there isn’t one. Numbness
Medically Reviewed by
Dr. Yelliann Ruiz Irizary, MD
Board Certified Rheumatologist
A blood test comes back negative, and the assumption that follows is almost automatic: no rheumatoid factor, no rheumatoid arthritis. That assumption is wrong often enough that it has its own name in medicine: seronegative rheumatoid arthritis, a real, damaging form of the disease that simply doesn’t show up on the standard antibody tests.
Somewhere between 20 and 30 percent of people with rheumatoid arthritis fall into this category. Their joints are just as inflamed, their disease just as capable of causing lasting damage, and yet their lab work tells a misleadingly reassuring story that can send both patients and providers looking in the wrong direction. Understanding what seronegative rheumatoid arthritis actually is, and why the negative test doesn’t mean what most people assume, can shorten the path to an accurate diagnosis considerably.
Rheumatoid arthritis is often diagnosed with the help of two blood markers: rheumatoid factor and anti-cyclic citrullinated peptide antibodies, usually shortened to anti-CCP. Most people with rheumatoid arthritis test positive for one or both of these markers, a pattern doctors refer to as seropositive disease.
Seronegative rheumatoid arthritis simply means a person has the clinical disease, joint inflammation, pain, swelling, and stiffness consistent with rheumatoid arthritis, without testing positive for either of those standard markers. The word describes what’s absent in the bloodwork, not what’s absent in the joints, which is an important distinction that gets lost in casual conversation about lab results.
It’s tempting to treat rheumatoid factor and anti-CCP tests as a definitive yes-or-no answer, but neither test is perfect. Rheumatoid factor can also be negative in a meaningful share of people who genuinely have rheumatoid arthritis, and it can occasionally be positive in people who don’t have the disease at all, including some healthy older adults.
Anti-CCP antibodies are more specific to rheumatoid arthritis than rheumatoid factor, but they still aren’t present in every case. Because of this, rheumatologists have always treated these tests as supporting evidence rather than a stand-alone diagnostic tool, weighing them alongside the physical exam, imaging, and the overall pattern of a person’s symptoms rather than letting one number make the call on its own.
Seronegative rheumatoid arthritis looks essentially the same as seropositive disease from the patient’s perspective. Pain and swelling in the small joints of the hands and feet, often symmetrically on both sides of the body, are typical. Morning stiffness lasting longer than an hour, fatigue, and joint tenderness that persists rather than resolving quickly are all common.
Some research suggests seronegative rheumatoid arthritis may involve slightly larger joints more often, like the wrists, knees, and shoulders, in addition to the small joints of the hands and feet, though there’s meaningful overlap between the two forms. The bottom line clinically is that you can’t reliably tell seronegative from seropositive rheumatoid arthritis just by how the joints feel, which is exactly why the lab results carry so much weight in the conversation despite their limitations.
Diagnosing seronegative rheumatoid arthritis is genuinely more challenging than diagnosing the seropositive form, precisely because the blood tests that often support an earlier diagnosis aren’t available as a shortcut. Without a positive antibody test pointing clearly in one direction, doctors have to rely more heavily on the physical exam, the specific pattern of joint involvement, imaging findings, and ruling out other conditions that can look similar.
This more painstaking process means people with seronegative rheumatoid arthritis sometimes go longer without a confirmed diagnosis than people whose bloodwork gives an early, clear signal. That delay matters, since earlier treatment generally leads to better long-term joint outcomes in rheumatoid arthritis overall, regardless of whether the antibodies ever show up in bloodwork at all.
Because the antibody tests aren’t available to help narrow things down, a few other conditions frequently enter the conversation when someone has inflammatory joint symptoms and negative bloodwork. Psoriatic arthritis, particularly in someone without an obvious psoriasis rash yet, can closely resemble seronegative rheumatoid arthritis in its early stages.
Other conditions in the seronegative spondyloarthropathy family, along with polymyalgia rheumatica in older adults and, less commonly, lupus, can all produce overlapping symptoms of joint pain, swelling, and stiffness without the classic rheumatoid arthritis antibodies. Viral infections can also cause a temporary, reactive joint inflammation that mimics early rheumatoid arthritis before resolving on its own within weeks, which is part of why rheumatologists are often cautious about labeling a new case too quickly.
Sorting through this list is exactly the kind of pattern-matching that benefits from a rheumatologist’s experience rather than a single lab value. The distribution of affected joints, whether the spine or lower back is involved, skin findings, and how symptoms have evolved over time all factor into narrowing down which of these overlapping conditions actually fits.
Diagnosing seronegative rheumatoid arthritis relies on a combination of factors rather than any single definitive test. The pattern of joint involvement, particularly symmetric small joint swelling, along with the duration and character of morning stiffness, carries significant weight.
Imaging, including ultrasound or MRI, can detect synovitis, the joint lining inflammation characteristic of rheumatoid arthritis, sometimes before it’s obvious on physical exam or visible on a standard X-ray. Inflammatory markers like C-reactive protein and erythrocyte sedimentation rate, while not specific to rheumatoid arthritis alone, can support the diagnosis when elevated alongside the clinical picture. Ruling out the look-alike conditions mentioned above is also a core part of reaching a confident diagnosis, often requiring more than one visit before the full picture comes together.
Not necessarily, and this is one of the more important points for anyone with this diagnosis to understand clearly. Seronegative rheumatoid arthritis can cause the same degree of joint inflammation, pain, and long-term joint damage as seropositive disease if it isn’t properly managed.
Some research has actually suggested certain seronegative patients experience more swollen joints at diagnosis, even though joint damage on imaging over time can look somewhat different between the two groups. What’s clear across the research is that seronegative status shouldn’t be interpreted as a milder or less urgent form of the disease, and it shouldn’t lower the priority placed on getting inflammation under control quickly once a diagnosis is confirmed.
Yes, in some cases. A portion of people initially diagnosed as seronegative go on to develop positive rheumatoid factor or anti-CCP antibodies later in the course of their disease. This shift doesn’t necessarily mean the underlying disease has changed, more that antibody levels can develop or become detectable later in some individuals.
This possibility is part of why a rheumatologist may recheck antibody levels periodically in someone with a seronegative diagnosis, particularly if the clinical picture changes or if the initial diagnosis is still being clarified. A shift to seropositive status later on doesn’t change the treatment approach dramatically, since management is guided primarily by disease activity and joint findings rather than antibody status alone.
It can be genuinely frustrating to have real, disabling joint symptoms and a lab report that looks unremarkable. But the absence of positive antibodies doesn’t change what’s actually happening inside the joints, and it shouldn’t change how seriously the symptoms are taken.
Getting a confirmed diagnosis, even a seronegative one, opens the door to the same disease-modifying treatment options used for seropositive rheumatoid arthritis, aimed at controlling inflammation before it causes lasting joint damage. Delaying that diagnosis because a single blood test came back negative risks the same joint deterioration that untreated seropositive disease can cause, since the joint itself doesn’t know or care what the lab report says.
This is why persistence matters if your symptoms genuinely fit the pattern described here, even after an initial evaluation didn’t turn up a clear answer. A second opinion or a more detailed workup with a rheumatologist experienced in seronegative presentations can make a meaningful difference in how quickly the right diagnosis and treatment plan come together.
Many of the same broad risk factors that apply to rheumatoid arthritis overall also apply to the seronegative form. Women are affected more often than men, and the disease commonly develops between ages 30 and 60, though it can appear outside that range as well.
Family history plays a role, since certain genetic markers associated with immune regulation increase risk for rheumatoid arthritis generally, including seronegative presentations. Smoking remains one of the more significant modifiable risk factors identified across research on rheumatoid arthritis, seronegative and seropositive alike, and quitting is one of the few concrete steps within a patient’s control. Some research has also suggested seronegative rheumatoid arthritis may be somewhat more common in older adults at the time of first diagnosis compared to seropositive disease, though both forms span a wide age range in practice.
One of the harder parts of seronegative rheumatoid arthritis is the period before a diagnosis is confirmed, when symptoms are real and disruptive but lab results haven’t offered a clear answer. This stretch can be frustrating, particularly if early evaluations suggested the joint pain was “probably nothing serious” based on a single negative test.
It helps to keep a simple record of which joints are affected, how long morning stiffness lasts, and how symptoms change over time, including any pattern of flares and calmer stretches. This kind of detailed history often carries real diagnostic weight for a rheumatologist piecing together a seronegative case, sometimes more than any single test result. Bringing that information to an appointment, rather than relying on memory alone, can meaningfully speed up the process of reaching a clear diagnosis and starting appropriate treatment sooner rather than later.
Certain genetic markers, particularly variations in genes related to immune system regulation, are associated with a higher risk of developing rheumatoid arthritis broadly, including seronegative presentations. These genetic associations aren’t used as a routine diagnostic test in typical clinical practice, but they help explain why the disease clusters in some families more than others.
Researchers continue to study whether seronegative and seropositive rheumatoid arthritis represent meaningfully different underlying immune processes or simply different points along the same broad disease spectrum. For patients, this ongoing research matters less than the practical reality that both forms need to be taken seriously and managed proactively once identified, regardless of how the science eventually settles that question.
If you’re experiencing joint pain, swelling, and prolonged morning stiffness, especially affecting the same joints on both sides of your body, it’s worth seeing a rheumatologist even if an initial blood test for rheumatoid factor came back negative. A specialist can look at the full clinical picture, exam findings, imaging, and symptom pattern, rather than relying on a single lab value to rule the condition in or out.
Our rheumatology team evaluates inflammatory joint symptoms regularly, including cases where standard antibody tests don’t provide a clear answer on their own, and can build a full clinical picture instead of leaning on one lab value. Learn more about our approach to rheumatoid arthritis care in Miami.
A negative rheumatoid factor or anti-CCP test feels like reassuring news, but it doesn’t reliably rule out rheumatoid arthritis. Seronegative rheumatoid arthritis is a real, clinically significant form of the disease that depends on a careful exam, imaging, and ruling out other conditions rather than a single blood draw. If your symptoms fit the pattern, the lab result alone shouldn’t be the final word, and it shouldn’t be the reason a real, treatable disease goes unaddressed.
Roughly 20 to 30 percent of people diagnosed with rheumatoid arthritis are seronegative, meaning they test negative for both rheumatoid factor and anti-CCP antibodies despite having the clinical disease.
Yes. Treatment approaches, including disease-modifying medications aimed at controlling the underlying inflammation, are generally similar regardless of antibody status, since the goal in both cases is protecting the joints from ongoing damage.
The exact reasons aren’t fully understood, but rheumatoid factor and anti-CCP simply aren’t present in every case of rheumatoid arthritis. Some researchers believe seronegative disease may represent a somewhat different immune pathway rather than a lesser version of the same disease.
It’s less common than confusion with other inflammatory conditions, but it can happen, especially early on. The distinguishing features, symmetric joint involvement, prolonged morning stiffness, and systemic symptoms like fatigue, generally point toward an inflammatory process rather than mechanical wear. See our full breakdown of osteoarthritis vs rheumatoid arthritis for a closer look at how the two are told apart.
It’s reasonable to discuss this with a rheumatologist, since antibody levels can occasionally become positive later in the disease course, and ongoing symptoms may need imaging or further evaluation regardless of a repeat antibody result.
Rheumatoid Arthritis Symptoms, Causes, & Risk Factors, NIAMS
Dr. Yelliann Ruiz Irizarry is a board-certified rheumatologist and internist, fellowship-trained at the University of Miami/Jackson Health System, with extensive experience in treating complex autoimmune and joint conditions. She serves as Director of Rheumatology and Joints at South Florida Multispecialty Medical Group, specializing in rheumatoid arthritis, lupus, gout, osteoporosis, and joint pain management.
Trust & Transparency: Editorial Policy | Contact Us
More To Explore
A burning sensation in the ball of the foot. A feeling like there’s a pebble in your shoe, even when there isn’t one. Numbness
A dull ache above the heel after a run. Morning stiffness in the back of the ankle that eases once you get moving around
©2026 South Florida Multispecialty Medical Group. All Rights Reserved.